NYSE: FIGSFigs Inc Stock
$4.01+0.13 (+3.35%)
Updated Apr 23, 2025
FIGS Price
$4.01
Fair Value Price
N/A
Market Cap
$651.71M
52 Week Low
$3.57
52 Week High
$7.06
P/E
200.5x
P/B
1.73x
P/S
1.89x
PEG
2.34x
Dividend Yield
N/A
Revenue
$555.56M
Earnings
$2.72M
Gross Margin
67.6%
Operating Margin
2.58%
Profit Margin
0.5%
Debt to Equity
0.35
Operating Cash Flow
$81M
Beta
1.61
Next Earnings
Jun 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
FIGS Overview
FIGS, Inc. sells scrubs and other medical apparel and products for medical professionals. The apparel is sold directly to consumers online rather than in medical supply stores. FIGS was founded in 2013 and is based in Santa Monica, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FIGS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Apparel Manufacturing
Industry Rating
A
FIGS
Ranked#9 of 17
Ranked#9 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $212.53 | A | |
| $60.39 | B | |
| $24.69 | B |
Be the first to know about important FIGS news, forecast changes, insider trades & much more!
FIGS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FIGS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FIGS ($4.01) is trading above its intrinsic value of $0.69, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FIGS is poor value based on its earnings relative to its share price (200.5x), compared to the US market average (26.95x)
P/E vs Market Valuation
FIGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FIGS due diligence checks available for Premium users.
Valuation
FIGS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
200.5x
Industry
13.91x
Market
26.95x
FIGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FIGS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FIGS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.73x
Industry
2.34x
FIGS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FIGS price to earnings growth (PEG)
For valuing profitable companies with growth potential
FIGS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
FIGS's financial health
Profit margin
Revenue
$151.8M
Net Income
$1.9M
Profit Margin
1.2%
FIGS's Earnings (EBIT) of $14.34M... subscribe to Premium to read more.
Interest Coverage Financials
FIGS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$509.8M
Liabilities
$132.7M
Debt to equity
0.35
FIGS's short-term assets ($382.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FIGS's short-term assets ($382.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FIGS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FIGS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$30.4M
Investing
-$31.1M
Financing
-$37.8M
FIGS's operating cash flow ($81.16M)... subscribe to Premium to read more.
Debt Coverage Financials
FIGS vs Apparel Manufacturing Stocks
Figs Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.